HKEX’s Aim to Become World’s #1 Biotech Listing Hub &…
With three years having passed since the Hong Kong Stock Exchange (HKEX)’s decision to allow pre-revenue biotechs to IPO, we look back at a stellar…
Tagged with Funding
Singapore: A Myriad of Biotech Financing Strategies
Since 2000, when Singapore first positioned biomedical research as the fourth pillar of the country’s economy, government funding towards innovative…
Dun Yang – President & CEO, Anticancer Bioscience
Anticancer Bioscience is an exciting international precision oncology company, applying synthetic lethal approaches to develop targeted cancer…
Fabian Gerber – Senior Relationship Manager Primary…
Fabian Gerber of SIX Swiss Exchange, Switzerland's principal stock exchange, outlines the importance of life sciences companies to the exchange,…
Ng Huck Hui – Assistant Chief Executive, Biomedical…
Professor Ng Huck Hui of A*Star's Biomedical Research Council outlines the evolution of Singapore's science and technology research and innovation…
Piers Ingram – Co-Founder & CEO, Hummingbird…
Dr Piers Ingram, PhD, co-founder, and CEO of Singapore-based biotech Hummingbird Bioscience, shares his motivation for establishing the company in…
Funding the Cell & Gene Therapy Boom
The ascent of cell and gene therapies (CGT) is commonly regarded as one of the momentous turning points in the history of the pharmaceuticals…
John-Arne Røttingen – CEO, The Research Council of Norway
John-Arne Røttingen, CEO of The Research Council of Norway shares his career journey from academia to industry, outlines his new role as Norway's…
Anne Kjersti Fahlvik – Executive Director, Industries,…
Anne Kjersti Fahlvik of the Research Council of Norway highlights the health sector’s increasing importance to the Nordic nation, the country’s…
China Pharma News Roundup August 2020
A roundup of the latest news from Chinese pharma, including Big Pharma players losing out in the latest round of domestic procurement bidding, updates…
Company Spotlight: I-Mab Biopharma
The only company in our Summer 2020 edition of InFocus: 5 Biotechs to Watch in China to be helmed by a non-founding CEO, I-Mab Biopharma has advanced…
Hong Kong Biotech IPOs since Listing Reform in April 2018
On 30 April 2018, Hong Kong Stock Exchange’s (HKEX’s) introduced a number of reforms to allow and support the listing of pre-profit biotech…
